X

Trial Profile

Open-label, single dose crossover, relative bioavailability study comparing 25 microg vaginal estradiol formulations TX 12004HR and Vagifem

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 28 Nov 2018

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Estradiol (Primary) ; Estradiol
Indications Atrophic vaginitis
Focus Pharmacokinetics

Most Recent Events

06 Oct 2018 Results assessing the physical characteristics of TX-004HR in a phase II study, two phase 1 studies and an in-vitro study, presented at the North American Menopause Society 2018 Annual Meeting
11 Feb 2014 New trial record
28 Jan 2014 Final results published in a TherapeuticsMD media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com